DNA SOLUTIONS

ww.dnasolutions.com

DNA Solutions have been assisting individuals around the globe with DNA Paternity & relationship analysis & were the first pioneering company offering DNA home kits to test for paternity and introduced these back in the 90’s. Many of our technical staff and management are ex-police and ex-military DNA testing forensic scientists, further enhancing the quality and range of our DNA tests. Processing occurs in our own DNA laboratory, our lab is capable of DNA ancestry testing, paternity testing, relationship tests, DNA banking and preservation, where we additionally carry out extensive research and development. We have offices and laboratories worldwide & serve thousands of individuals and organizations globally

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Cell and Gene Therapy, MedTech

PEAR THERAPEUTICS AND SPERO HEALTH TO COLLABORATE AND EXPAND ACCESS TO PDTS

Pear Therapeutics | January 09, 2023

news image

Pear Therapeutics, Inc., the leader in commercializing and developing software-based medicines known as prescription digital therapeutics (PDTs), announced the expansion of its collaboration with Spero Health, an integrated healthcare services organization. Spero Health, which has adopted reSET® and reSET-O® at 14 locations in Kentucky, plans to expand access to eligible patients at its remaining 99 locations in Kentucky, Indiana, Ohio, Tennessee, Virginia, and West Virgin...

Read More

Cell and Gene Therapy

TERUMO BLOOD AND CELL TECHNOLOGIES TO COLLABORATE WITH CSL PLASMA ON U.S. FDA CLEARANCE OF PLASMA COLLECTION TECHNOLOGY

CSL Plasma | March 11, 2022

news image

CSL Plasma, a division of global biotherapeutics pioneer CSL Behring, announced the Rika Plasma Donation System created by Terumo Blood and Cell Technologies, a medical technology company based in Lakewood, Colorado, has received regulatory approval. The new plasmapheresis system is expected to provide technologies to support a safe, efficient, and better experience for plasma donors and an improved experience for CSL Plasma personnel, according to Terumo Blood and Cell Technologi...

Read More

Medical

BIO-TECHNE AND CYGNUS TECHNOLOGIES PRESENT PLEX HEK 293 HCP 3G IMMUNOASSAY

Bio-Techne Corporation | April 13, 2022

news image

Bio-Techne Corporation launched 3G assay for automated process impurity assessment on the EllaTM immunoassay platform ( NASDAQ: TECH ) and Cygnus Technologies, a division of Maravai LifeSciences ( NASDAQ: MRVI ). In cell and gene therapy applications, the purification of viral particles to reduce host cell protein (HCP) contamination is an important part of the viral production workflow. To guarantee HCP impurity clearance is performed in compliance with regulatory criteria, accurate quan...

Read More

Cell and Gene Therapy

MODERNA AND ALDEVRON ANNOUNCE EXPANDED COLLABORATION FOR MRNA VACCINE AND THERAPEUTIC PIPELINE

Moderna, Aldevron | May 25, 2021

news image

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Aldevron, LLC, the leading provider of high-quality plasmid DNA, mRNA, and recombinant proteins used for vaccines, gene and cell therapy, gene editing, and diagnostic applications, have announced an expanded collaboration in support of the Moderna COVID-19 Vaccine and additional programs in mRNA therapeutics and vaccines. Aldevron will specifically provide plasmid DNA to act as th...

Read More
news image

Cell and Gene Therapy, MedTech

PEAR THERAPEUTICS AND SPERO HEALTH TO COLLABORATE AND EXPAND ACCESS TO PDTS

Pear Therapeutics | January 09, 2023

Pear Therapeutics, Inc., the leader in commercializing and developing software-based medicines known as prescription digital therapeutics (PDTs), announced the expansion of its collaboration with Spero Health, an integrated healthcare services organization. Spero Health, which has adopted reSET® and reSET-O® at 14 locations in Kentucky, plans to expand access to eligible patients at its remaining 99 locations in Kentucky, Indiana, Ohio, Tennessee, Virginia, and West Virgin...

Read More
news image

Cell and Gene Therapy

TERUMO BLOOD AND CELL TECHNOLOGIES TO COLLABORATE WITH CSL PLASMA ON U.S. FDA CLEARANCE OF PLASMA COLLECTION TECHNOLOGY

CSL Plasma | March 11, 2022

CSL Plasma, a division of global biotherapeutics pioneer CSL Behring, announced the Rika Plasma Donation System created by Terumo Blood and Cell Technologies, a medical technology company based in Lakewood, Colorado, has received regulatory approval. The new plasmapheresis system is expected to provide technologies to support a safe, efficient, and better experience for plasma donors and an improved experience for CSL Plasma personnel, according to Terumo Blood and Cell Technologi...

Read More
news image

Medical

BIO-TECHNE AND CYGNUS TECHNOLOGIES PRESENT PLEX HEK 293 HCP 3G IMMUNOASSAY

Bio-Techne Corporation | April 13, 2022

Bio-Techne Corporation launched 3G assay for automated process impurity assessment on the EllaTM immunoassay platform ( NASDAQ: TECH ) and Cygnus Technologies, a division of Maravai LifeSciences ( NASDAQ: MRVI ). In cell and gene therapy applications, the purification of viral particles to reduce host cell protein (HCP) contamination is an important part of the viral production workflow. To guarantee HCP impurity clearance is performed in compliance with regulatory criteria, accurate quan...

Read More
news image

Cell and Gene Therapy

MODERNA AND ALDEVRON ANNOUNCE EXPANDED COLLABORATION FOR MRNA VACCINE AND THERAPEUTIC PIPELINE

Moderna, Aldevron | May 25, 2021

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Aldevron, LLC, the leading provider of high-quality plasmid DNA, mRNA, and recombinant proteins used for vaccines, gene and cell therapy, gene editing, and diagnostic applications, have announced an expanded collaboration in support of the Moderna COVID-19 Vaccine and additional programs in mRNA therapeutics and vaccines. Aldevron will specifically provide plasmid DNA to act as th...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us